📊 ABSI Key Takeaways
Is Absci Corp (ABSI) a Good Investment?
Absci is in critical financial distress with minimal revenue of $215K and operating losses of $30.8M, indicating fundamental business model failure. Operating cash flow of -$26.3M combined with only $8.6M in cash creates a runway of approximately 4 months, with no evident path to profitability or positive unit economics.
Absci's fundamentals are very weak: revenue is minimal and flat at $2.15M while operating and net losses remain extremely large relative to the business size, producing deeply negative margins and cash flow. The balance sheet is not highly levered and current liquidity ratios look strong, but the combination of only $9.48M in cash against substantial operating cash burn suggests limited runway and a high likelihood that growth will require external funding. Until revenue scales meaningfully and losses narrow materially, the growth quality appears poor.
Why Buy Absci Corp Stock? ABSI Key Strengths
- Low leverage with Debt/Equity ratio of 0.02x and only $4.0M long-term debt
- Substantial equity base of $172M provides temporary balance sheet cushion
- Minimal capital requirements evident from $30K CapEx spending demonstrates lean operations
- Low financial leverage with debt/equity of 0.02x and limited long-term debt
- Strong reported current and quick ratios, indicating near-term balance sheet flexibility
- Large equity base relative to liabilities provides some balance sheet support
ABSI Stock Risks: Absci Corp Investment Risks
- Critical cash runway of approximately 4 months at current annual operating burn of $26.3M
- Revenue collapse with $215K quarterly revenue down 38.2% YoY indicating market rejection
- Operating losses of $30.8M against minimal revenue signal fundamental business failure
- Negative operating cash flow with no discernible path to profitability or cash flow positivity
- Revenue is very small and showed no year-over-year growth, indicating weak commercial traction
- Extreme negative profitability with operating margin of -4152.4% and net margin of -3982.4%
- Operating cash burn is severe relative to cash on hand, increasing financing and dilution risk
Key Metrics to Watch
- Monthly cash burn and remaining runway until depletion
- Revenue trends and any customer win announcements
- Operating cash flow and cost reduction initiatives
- Debt and financing activity including potential dilutive capital raises
- Quarterly revenue growth and evidence of commercial scaling
- Operating cash burn relative to cash balance and resulting funding runway
Absci Corp (ABSI) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.59x current ratio provides a solid financial cushion.
ABSI Profit Margin, ROE & Profitability Analysis
ABSI vs Healthcare Sector: How Absci Corp Compares
How Absci Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Absci Corp Stock Overvalued? ABSI Valuation Analysis 2026
Based on fundamental analysis, Absci Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Absci Corp Balance Sheet: ABSI Debt, Cash & Liquidity
ABSI Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Absci Corp's revenue has grown significantly by 10% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.94 indicates the company is currently unprofitable.
ABSI Revenue Growth, EPS Growth & YoY Performance
ABSI Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $215.0K | -$26.3M | $-0.19 |
| Q3 2025 | $378.0K | -$22.0M | $-0.20 |
| Q2 2025 | $593.0K | -$22.0M | $-0.22 |
| Q1 2025 | $898.0K | -$22.0M | $-0.21 |
| Q3 2024 | $744.0K | -$22.0M | $-0.24 |
| Q2 2024 | $1.3M | -$22.0M | $-0.22 |
| Q1 2024 | $898.0K | -$22.0M | $-0.22 |
| Q3 2023 | $744.0K | -$22.0M | $-0.24 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Absci Corp Dividends, Buybacks & Capital Allocation
ABSI SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Absci Corp (CIK: 0001672688)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ABSI
What is the AI rating for ABSI?
Absci Corp (ABSI) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 88% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ABSI's key strengths?
Claude: Low leverage with Debt/Equity ratio of 0.02x and only $4.0M long-term debt. Substantial equity base of $172M provides temporary balance sheet cushion. ChatGPT: Low financial leverage with debt/equity of 0.02x and limited long-term debt. Strong reported current and quick ratios, indicating near-term balance sheet flexibility.
What are the risks of investing in ABSI?
Claude: Critical cash runway of approximately 4 months at current annual operating burn of $26.3M. Revenue collapse with $215K quarterly revenue down 38.2% YoY indicating market rejection. ChatGPT: Revenue is very small and showed no year-over-year growth, indicating weak commercial traction. Extreme negative profitability with operating margin of -4152.4% and net margin of -3982.4%.
What is ABSI's revenue and growth?
Absci Corp reported revenue of $215.0K.
Does ABSI pay dividends?
Absci Corp does not currently pay dividends.
Where can I find ABSI SEC filings?
Official SEC filings for Absci Corp (CIK: 0001672688) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ABSI's EPS?
Absci Corp has a diluted EPS of $-0.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ABSI a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Absci Corp has a STRONG SELL rating with 88% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ABSI stock overvalued or undervalued?
Valuation metrics for ABSI: ROE of -17.2% (sector avg: 15%), net margin of -13,767.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy ABSI stock in 2026?
Our dual AI analysis gives Absci Corp a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ABSI's free cash flow?
Absci Corp's operating cash flow is $-26.3M, with capital expenditures of $30.0K. FCF margin is -12,249.8%.
How does ABSI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -13,767.0% (avg: 12%), ROE -17.2% (avg: 15%), current ratio 6.59 (avg: 2).